Detalhe da pesquisa
1.
The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice.
Curr Cardiol Rep
; 23(11): 163, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34599393
2.
CSAR: a contig scaffolding tool using algebraic rearrangements.
Bioinformatics
; 34(1): 109-111, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968788
3.
Multi-CAR: a tool of contig scaffolding using multiple references.
BMC Bioinformatics
; 17(Suppl 17): 469, 2016 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28155633
4.
Climate Change and Cardiovascular Health: A Systematic Review.
JAMA Cardiol
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38865135
5.
Cost-Effectiveness of Antibiotic-Eluting Envelope for Prevention of Cardiac Implantable Electronic Device Infections in Heart Failure.
Circ Cardiovasc Qual Outcomes
; 15(3): e008443, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35105176
6.
Cost-effectiveness of Dapagliflozin for the Treatment of Heart Failure With Reduced Ejection Fraction.
JAMA Netw Open
; 4(7): e2114501, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34313742
7.
Cost-effectiveness and affordability of novel cardiovascular therapies: what physicians need to know.
Heart
; 107(15): 1267-1268, 2021 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33858957